More Articles on Orthopedic Devices:
13 Spine Devices Receive FDA 510(k) Clearance in September
How A Facility Implements Generic Orthopedic Implants
Pinnacle Spine Group Wins FDA Approval for Direct Lateral System
a
NuVasive 3Q Forecast Shows Disappointing Revenue Decrease Featured
Written by Jaimie Oh | October 04, 2012
NuVasive forecasted a fall in third quarter revenue, from $154.4 million in the second quarter to approximately $147 million, according to a Bloomberg Businessweek report.
The fall in revenue was driven by competitor discounts and an increase in coverage denials and delays by healthcare payors. The device company will release its third quarter financial results later this month.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.